Sponsor Led Roundtable: Addressing Manufacturing Challenges with Gene-Editing Technologies for iPSC Therapeutics
25 Jun 2024
Salon A
iPSCs Technology
)
- What are the manufacturing implications of the recent FDA guidelines from January 2024 on “Human Gene Therapy Products Incorporating Human Genome Editing”?
- How do manufacturing requirements differ for gene-editing of master cell banks versus drug substances/drug products?
- How can gene-editing technologies be manufactured to meet appropriate quality attributes?
Industry Expert
